Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

PubMed

Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine.

PMID : 28185142 ·

F, r, e, d, e, r, i, c, , G, i, l, b, e, r, t, ;, , C, a, t, h, a, l, , D, , O, ', C, o, n, n, e, l, l, ;, , T, a, j, a, n, k, a, , M, l, a, d, e, n, o, v, s, k, a, ;, , S, u, s, a, n, , D, o, d, d, s

RevueScience and engineering ethics
Année
PMID28185142

Résumé

Recent developments of three-dimensional printing of biomaterials (3D bioprinting) in medicine have been portrayed as demonstrating the potential to transform some medical treatments, including providing new responses to organ damage or organ failure. However, beyond the hype and before 3D bioprinted organs are ready to be transplanted into humans, several important ethical concerns and regulatory questions need to be addressed. This article starts by raising general ethical concerns associated

Source officielle

Voir sur PubMed →

Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.

↑